Drew Oetting
co-founder, Director @ Resilience
San Francisco, United States
Drew Oetting is a Series A investor at Resilience in San Francisco focused on Marketing and E-Commerce. Drew is a founding partner of 8VC. He focuses on investments across various stages and sectors including vertical software, health delivery, and biomanufacturing.He is also a founding Board Director of Affinity Technologies, an early-stage enterprise software company. Previously Drew was a partner at Formation 8. Before that, he served as Chiefof Staff to Joe Lonsdale.Drew began his career as an analyst in the Technology Investment Banking Division of Moelis & Company in Palo Alto, California where he focused on M&A advisory in the Internet/Digital Media and Network Infrastructure industries. While in college Drew worked in the private equity group of Cascade Investment in Kirkland, Washington as well as for Asia Pacific Investment Partners, a Hong Kong-holdings company focused on real estate and mining investments in Mongolia.Drew received a B.A. in Economics and Mathematics cum laude from Claremont McKenna College in Claremont, California.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Drew Oetting invests in
Stages Drew Oetting invests in
Countries Drew Oetting invests in
Investment Focus
Industry
- Marketing 2 (14%)
- E-Commerce 2 (14%)
- Health Care 2 (14%)
- SaaS 1 (7%)
- Retail 1 (7%)
Stage
- Series A 4 (29%)
- Seed 3 (21%)
- Series B 3 (21%)
- Pre-Seed 1 (7%)
- Series C 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Raydiant is the leading in-location Experience OS for the world's most renowned restaurants, retail, hospitality, banking, and brands. With Raydiant, franchise managers, IT, marketing, and communications executives can scale their brick-and-mortar operations more effectively, reduce anxiety from outdated technology oversight, and seamlesslycreate more engaging and personalized in-store experiences that keep customers buying more. Raydiant works with nearly 5,500 brands, from SMB to enterprise, including Johnson and Johnson, Nestlé, Unilever, The Estée Lauder Companies, Paradies Legerdiere, Red Bull, Chick-Fil-A, Sunglass Hut, and Wahlburgers. Founded in April 2017, Raydiant is headquartered in San Francisco, California, and has raised $50 million from 8VC, Atomic Ventures, Lerer Hippeau, Mark Wahlberg Investments, Bloomberg Beta, Gaingels, Illuminate Ventures, Transmedia Capital, Ron Conway. To learn more, visit www.raydiant.com. | $30M / Series B / Feb 16, 2022 | |
|
|
Better Health is a support and supplies platform built on peer-to-peer connection. The supported chronic conditions include ostomy, chronic wounds, diabetes, chronic retention, and incontinence. Better Health is trusted by healthcare payers and providers to deliver peer support, education, and medical supplies to drive engagement and adherence,improve outcomes, and lower the cost of care. The result is reduced overutilization, improved mental health, and a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health operates in 48 states and serves the members of top payers, including Medicare, Medicaid, Cigna, Humana, Florida Blue, and Oscar, among others. To learn more, visit joinbetter.com. | $10M / Series A / Oct 13, 2021 | |
|
|
Karat is the talent elevation partner that helps technical leaders transform their workforce as AI reshapes essential skillsets. We help companies like Citi, PayPal, and Duolingo evaluate and benchmark engineering talent rigorously, consistently, and at scale. Our system then turns those evaluations into insights that help leaders build a morecapable and competitive workforce. Karat’s interviews are designed with best-in-class methodologies and live AI-native scenarios, consistently delivered by experienced Interview Engineers. With intelligence from more than 600,000 technical evaluations, leaders gain deep understanding of their workforce capabilities, competitive perspective, and confidence that standards are being met to thrive in the Human + AI era. Learn more at karat.com. | $110M / Series C / Oct 13, 2021 | |
|
|
Better Health is a support and supplies platform built on peer-to-peer connection. The supported chronic conditions include ostomy, chronic wounds, diabetes, chronic retention, and incontinence. Better Health is trusted by healthcare payers and providers to deliver peer support, education, and medical supplies to drive engagement and adherence,improve outcomes, and lower the cost of care. The result is reduced overutilization, improved mental health, and a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health operates in 48 states and serves the members of top payers, including Medicare, Medicaid, Cigna, Humana, Florida Blue, and Oscar, among others. To learn more, visit joinbetter.com. | $3.5M / Seed / Mar 25, 2021 | |
|
|
Raydiant is the leading in-location Experience OS for the world's most renowned restaurants, retail, hospitality, banking, and brands. With Raydiant, franchise managers, IT, marketing, and communications executives can scale their brick-and-mortar operations more effectively, reduce anxiety from outdated technology oversight, and seamlesslycreate more engaging and personalized in-store experiences that keep customers buying more. Raydiant works with nearly 5,500 brands, from SMB to enterprise, including Johnson and Johnson, Nestlé, Unilever, The Estée Lauder Companies, Paradies Legerdiere, Red Bull, Chick-Fil-A, Sunglass Hut, and Wahlburgers. Founded in April 2017, Raydiant is headquartered in San Francisco, California, and has raised $50 million from 8VC, Atomic Ventures, Lerer Hippeau, Mark Wahlberg Investments, Bloomberg Beta, Gaingels, Illuminate Ventures, Transmedia Capital, Ron Conway. To learn more, visit www.raydiant.com. | $13M / Series A / Jan 28, 2021 | |
|
|
Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions. | $750M / Series B / Nov 23, 2020 | |
|
|
Karat is the talent elevation partner that helps technical leaders transform their workforce as AI reshapes essential skillsets. We help companies like Citi, PayPal, and Duolingo evaluate and benchmark engineering talent rigorously, consistently, and at scale. Our system then turns those evaluations into insights that help leaders build a morecapable and competitive workforce. Karat’s interviews are designed with best-in-class methodologies and live AI-native scenarios, consistently delivered by experienced Interview Engineers. With intelligence from more than 600,000 technical evaluations, leaders gain deep understanding of their workforce capabilities, competitive perspective, and confidence that standards are being met to thrive in the Human + AI era. Learn more at karat.com. | $17.5M / Venture - Series Unknown / Oct 31, 2020 | |
|
|
Raydiant is the leading in-location Experience OS for the world's most renowned restaurants, retail, hospitality, banking, and brands. With Raydiant, franchise managers, IT, marketing, and communications executives can scale their brick-and-mortar operations more effectively, reduce anxiety from outdated technology oversight, and seamlesslycreate more engaging and personalized in-store experiences that keep customers buying more. Raydiant works with nearly 5,500 brands, from SMB to enterprise, including Johnson and Johnson, Nestlé, Unilever, The Estée Lauder Companies, Paradies Legerdiere, Red Bull, Chick-Fil-A, Sunglass Hut, and Wahlburgers. Founded in April 2017, Raydiant is headquartered in San Francisco, California, and has raised $50 million from 8VC, Atomic Ventures, Lerer Hippeau, Mark Wahlberg Investments, Bloomberg Beta, Gaingels, Illuminate Ventures, Transmedia Capital, Ron Conway. To learn more, visit www.raydiant.com. | $7M / Series A / Oct 23, 2019 | |
|
|
Karat is the talent elevation partner that helps technical leaders transform their workforce as AI reshapes essential skillsets. We help companies like Citi, PayPal, and Duolingo evaluate and benchmark engineering talent rigorously, consistently, and at scale. Our system then turns those evaluations into insights that help leaders build a morecapable and competitive workforce. Karat’s interviews are designed with best-in-class methodologies and live AI-native scenarios, consistently delivered by experienced Interview Engineers. With intelligence from more than 600,000 technical evaluations, leaders gain deep understanding of their workforce capabilities, competitive perspective, and confidence that standards are being met to thrive in the Human + AI era. Learn more at karat.com. | $28M / Series B / May 15, 2019 | |
|
|
AgVend provides digital enablement solutions for agribusinesses. With their solutions, they connect technology systems and centralize information across the business. Their sales hub and customer portal connect and organizes disparate information, enabling users to have an up-to-date digital experience. | $1.8M / Seed / Apr 04, 2018 | |
| See all 14 investments → | |||
Co-Investors
About Resilience
Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.
Resilience Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bill Reid
CISO and VP, Security and Privacy
|
|||
|
Eytan Abraham
VP, Head of Cell Therapy Franchise
|
|||
|
Rahul Singhvi
Co-Founder & CEO
|
|||
|
Ross Leimberg
Senior Director of Business Development
|
|||
|
Sandy Mahatme
President, COO and CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Drew Oetting invest in?
Drew Oetting invests primarily in Marketing, E-Commerce and Health Care startups, most often at Series A and Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Drew Oetting last invest?
The most recent investment recorded for Drew Oetting closed in Feb 2022. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!